GlassScriptPhysician profile
Qiying She
NPI 1962990135
$2,413.64
in general payments reported to CMS, 2019-2025
17 companies · $40.86 in 2025
The $40.86 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $333 · 2022: $356 · 2023: $591 · 2024: $1,093 · 2025: $40.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,724.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,033.29 | 2021-2025 | Proclaim, Eterna |
| Medtronic, INC. | $612.22 | 2022-2024 | Intellis Adaptivestim, Synchromedii, Aquamantys(Tm) |
| Nalu Medical, INC. | $140.55 | 2022-2024 | Nalu Neurostimulation System |
| Biohaven Pharmaceuticals, INC. | $94.35 | 2021 | |
| Spr Therapeutics, INC | $80.81 | 2024 | Sprint Pns System |
| Saluda Medical Americas, INC. | $77.88 | 2023 | Evoke Scs |
| Collegium Pharmaceutical, INC. | $68.97 | 2021 | |
| Nevro Corp. | $66.83 | 2023 | Senza |
| Abbvie INC. | $47.36 | 2021 | |
| Convatec INC. | $38.71 | 2023-2024 | |
| Amgen INC. | $34.64 | 2021 | |
| Orexo US, INC. | $27.71 | 2021 | |
| Biotronik Nro, INC. | $24.05 | 2025 | Prospera |
| Boston Scientific Corporation | $19.36 | 2022 | |
| Grt US Holding, INC. | $17.97 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $17.73 | 2021 | |
| Relievant Medsystems, INC. | $11.21 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Qiying She listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.